Abstract: Disclosed is a compound represented by the general formula (1) or a salt thereof. The compound or a salt thereof has an inhibitory activity on IKK? and is therefore useful as preventive and/or therapeutic agent for a disease associated with IKK?. In the formula, R1 represents a hydrogen atom, a lower alkyl group, an aryl group, a hydroxy group, or the like; R2 represents a halogen atom, a lower alkyl group, a lower alkenyl group, a lower alkynyl group, or the like; and m represents 0, 1, 2, or the like.
Abstract: L-DOPA amide derivatives, pharmaceutical compositions containing same and their use in the treatment of conditions associated with impaired dopaminergic activity/signaling (e.g., Parkinson disease) are disclosed.
Type:
Grant
Filed:
August 4, 2005
Date of Patent:
November 1, 2011
Assignee:
Yissum Research Development Company of the Hebrew University of Jerusalem
Abstract: The present invention provides compounds useful as agents for the prevention or treatment of a disease associated with abnormal serum uric acid level which has a uricosuric activity or the like. The present invention relates to (aza)indole derivatives represented by the following general formula (I) having xanthine oxidase inhibitory activities and useful as agents for the prevention or treatment of a disease associated with abnormality of serum uric acid level, prodrugs thereof, or salts thereof.
Abstract: The present invention relates to Cycloalkane-substituted substituted pyrazoline compounds of formula (I), methods for their preparation, medicaments comprising these compounds as well as their use for the preparation of a medicament for the treatment of humans and animals.
Type:
Grant
Filed:
July 17, 2006
Date of Patent:
August 9, 2011
Assignee:
Laboratorios del Dr. Esteve, S.A.
Inventors:
Antonio Torrens Jover, Susana Yenes Minguez
Abstract: Isoxazole derivatives, in particular diarylisoxazole derivatives inhibitors of cyclooxygenase (COX), in particular cyclooxygenase-1 (COX-1), their pharmaceutical compositions, the process for their preparation and their use for the chemoprevention and treatment of inflammatory syndromes and in the prevention and treatment of carcinomas, in particular intestinal, ovarian and cutaneous carcinomas, in the treatment of pain syndromes, in particular after surgery, and in the cardiovascular field as antithrombotics/vasoprotectives/cardioprotectives.
Type:
Grant
Filed:
January 11, 2008
Date of Patent:
August 2, 2011
Assignees:
Universita' Degli Studi Di Bari, Universita' Degli Studi “G.D.'Annunzio”—Chieti
Inventors:
Antonio Scilimati, Paola Vitale, Leonardo Di Nunno, Paola Patrignani, Stefania Tacconelli, Marta Luciana Capone
Abstract: The present invention provides a process for preparing thiazole derivatives of formula (I), that activate the delta subtype of the human Peroxisome Proliferator Activated Receptor (hPPAR ?), and also provides compounds of formula (II), (IV), (X), (XI) and (XII), intermediate compounds for preparation of the above compounds of formula (I).
Type:
Grant
Filed:
May 7, 2005
Date of Patent:
July 19, 2011
Assignee:
Seoul National University Industry Foundation